Reports for AA PHARMA INC
Company Name AA PHARMA INC |
||
|---|---|---|
Totals |
||
Shortage reports |
446 |
|
| Actual shortage: | 21 (5%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 6 (1%) | |
| Resolved: | 419 (94%) | |
Discontinuation Reports |
63 |
|
| To be discontinued: | 9 (14%) | |
| Discontinued: | 52 (83%) | |
| Reversed: | 2 (3%) | |
Late reports |
30 (6%) |
|
Overdue reports |
20 (67%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| KETOROLAC | 0.5% | SOLUTION | Resolved | 2019-12-19 | 2020-03-04 | 101640 |
| KETOROLAC | 0.5% | SOLUTION | Resolved | 2021-04-20 | 2021-06-24 | 137758 |
| KETOROLAC | 0.5% | SOLUTION | Resolved | 2022-07-22 | 2022-08-25 | 165271 |
| KETOROLAC | 0.5% | SOLUTION | Resolved | 2022-07-27 | 2022-08-25 | 165600 |
| KETOROLAC | 0.5% | SOLUTION | Resolved | 2023-03-08 | 2023-06-13 | 186515 |
| KETOROLAC | 0.5% | SOLUTION | Resolved | 2023-03-30 | 2023-06-13 | 188326 |
| KETOROLAC | 0.5% | SOLUTION | Resolved | 2023-06-14 | 2023-10-04 | 194899 |
| KETOROLAC | 0.5% | SOLUTION | Resolved | 2023-07-14 | 2023-10-04 | 198735 |
| KETOROLAC | 0.5% | SOLUTION | Resolved | 2023-11-15 | 2024-01-31 | 210268 |
| KETOROLAC | 0.5% | SOLUTION | Resolved | 2024-07-11 | 2024-08-16 | 232781 |
| LITHMAX | 300MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-12-07 | 2024-01-20 | 212786 |
| LITHMAX | 300MG | TABLET (EXTENDED-RELEASE) | Resolved | 2024-03-11 | 2024-08-06 | 221857 |
| LORAZEPAM SUBLINGUAL | 0.5MG | TABLET | Resolved | 2023-02-03 | 2023-04-17 | 183599 |
| LORAZEPAM SUBLINGUAL | 0.5MG | TABLET | Resolved | 2023-05-11 | 2023-07-15 | 192270 |
| LORAZEPAM SUBLINGUAL | 1MG | TABLET | Resolved | 2021-09-09 | 2021-09-30 | 145410 |
| LORAZEPAM SUBLINGUAL | 1MG | TABLET | Resolved | 2023-02-28 | 2023-05-01 | 185682 |
| LOVASTATIN | 40MG | TABLET | Resolved | 2025-03-19 | 2025-05-01 | 253032 |
| MEFENAMIC | 250MG | CAPSULE | Resolved | 2021-07-08 | 2021-07-14 | 142026 |
| MEFENAMIC | 250MG | CAPSULE | Resolved | 2023-11-15 | 2024-01-31 | 210273 |
| MEFENAMIC | 250MG | CAPSULE | Resolved | 2024-07-31 | 2024-09-05 | 234154 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO CIMETIDINE TAB 300MG | 300MG | TABLET | To be discontinued | 2019-01-02 | 2019-01-02 | 70796 |
| APO CIMETIDINE TAB 600MG | 600MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60376 |
| APO DIAZEPAM TAB 10MG | 10MG | TABLET | Discontinued | 2018-09-07 | 2018-10-05 | 60417 |
| APO DIAZEPAM TAB 2MG | 2MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60411 |
| APO DIAZEPAM TAB 5MG | 5MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60414 |
| APO DILTIAZ TAB 30MG | 30MG | TABLET | Discontinued | 2018-09-07 | 2019-07-13 | 60429 |
| APO SULFATRIM DS TAB | 800MG 160MG | TABLET | Discontinued | 2018-09-10 | 2018-09-15 | 61039 |
| APO SULFATRIM TAB | 400MG 80MG | TABLET | Discontinued | 2018-09-10 | 2018-11-09 | 61036 |
| APO-AMILZIDE TAB | 50MG 5MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60166 |
| APO-ATENIDONE | 25MG 50MG | TABLET | Discontinued | 2017-03-30 | 2018-02-05 | 4702 |
| APO-ATENIDONE | 25MG 100MG | TABLET | Discontinued | 2017-03-30 | 2018-02-05 | 4698 |
| APO-CIMETIDINE TAB 800MG | 800MG | TABLET | Discontinued | 2017-03-13 | 2018-09-21 | 1061 |
| APO-FENO-MICRO | 200MG | CAPSULE | Discontinued | 2018-09-07 | 2019-02-13 | 60483 |
| APO-FENO-SUPER | 100MG | TABLET | Discontinued | 2017-03-30 | 2018-02-05 | 4710 |
| APO-FENO-SUPER | 160MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60486 |
| APO-FENOFIBRATE | Discontinued | 2019-01-03 | 2019-01-03 | 70900 | ||
| APO-LOVASTATIN - TAB 20MG | 20MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60606 |
| APO-MEDROXY TABLETS | 2.5MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60609 |
| APO-MINOCYCLINE CAP 100MG | 100MG | CAPSULE | Discontinued | 2017-03-30 | 2018-02-05 | 4728 |
| APO-MINOCYCLINE CAP 50MG | 50MG | CAPSULE | Discontinued | 2017-03-30 | 2018-02-05 | 4731 |